4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ABBVIE

Period 4th Quarter 2018 Filed Jan 20, 2019 Signed by Marc S. Lampkin, Attorney at Law

Official filing
Firm
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Client
ABBVIE
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to trade treaty legislation

LobbyistCovered position, as disclosed
ELIZABETH ANNE MAIER —

Contacted: SENATE; Executive Office of the President (EOP); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform Medicare Part D

LobbyistCovered position, as disclosed
LAURA JOHNSON BOLLIER —
MARC LAMPKIN —
ELIZABETH ANNE MAIER —
BRIAN THOMAS MCGUIRE —
ALFRED MOTTUR —
ZACHARY PFISTER —

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.